Platinum-Refractory Primary Peritoneal Carcinoma

specific

Primary peritoneal carcinoma that progresses during platinum therapy or within one month of completing platinum therapy.

35

Centers

35

Active Trials

Cancer Funding

Top Centers for Platinum-Refractory Primary Peritoneal Carcinoma(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.4
2
NCI Comprehensive
Active Research Program
51.4
3
NCI Comprehensive
Active Research Program
51.4
4
NCI Comprehensive
Active Research Program
51.4
5
NCI Comprehensive
Active Research Program
51.4
6
NCI Comprehensive
Active Research Program
51.4
751.4
8
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.4
9
NCI Comprehensive
Active Research Program
51.4
10
NCI Comprehensive
Active Research Program
51.4
11
NCI Comprehensive
Active Research Program
51.4
12
NCI Comprehensive
Active Research Program
51.4
13
NCI Comprehensive
Active Research Program
51.4
14
NCI Comprehensive
Active Research Program
51.4
15
NCI Comprehensive
Active Research Program
51.4
16
NCI Clinical
Active Research Program
51.4
17
NCI Comprehensive
Active Research Program
51.4
18
Active Research Program
51.4
19
Active Research Program
51.4
20
NCI Comprehensive
Active Research Program
51.4
21
NCI Clinical
Active Research Program
51.4
22
NCI Comprehensive
Active Research Program
51.4
23
Active Research Program
51.4
24
NCI Clinical
Active Research Program
51.4
25
NCI Comprehensive
Active Research Program
51.4
26
Active Research Program
51.4
2751.4
28
Active Research Program
51.4
29
Active Research Program
51.4
30
Active Research Program
51.4
31
Active Research Program
51.4
3251.4
33
Active Research Program
51.4
34
Active Research Program
51.4
35
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →